Ubs Group Ag Procaps Group, S.A. Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Procaps Group, S.A. stock. As of the latest transaction made, Ubs Group Ag holds 49 shares of PROC stock, worth $65. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49Holding current value
$65% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding PROC
# of Institutions
7Shares Held
235KCall Options Held
0Put Options Held
0-
Itau Unibanco Holding S.A. Sao Paulo, D5178KShares$236,7050.01% of portfolio
-
Geode Capital Management, LLC Boston, MA33.3KShares$44,3100.0% of portfolio
-
United Maritime Capital LLC New York, NY14KShares$18,6200.64% of portfolio
-
Activest Wealth Management10KShares$13,3000.01% of portfolio
-
Morgan Stanley New York, NY100Shares$1330.0% of portfolio
About Procaps Group, S.A.
- Ticker PROC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 112,824,000
- Market Cap $150M
- Description
- Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...